Latest News about AWKNF
Recent news which mentions AWKNF
Awakn's Study On Psychedelics For Treating Addiction Shows Promise, Will Undertake Broader Research
May 19, 2022
Tickers
AWKNF
From Benzinga
From Benzinga
Core One Labs Begins Trading On OTCQB
April 06, 2022
From Benzinga
Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!
April 06, 2022
From Benzinga
Stifel Initiates Coverage On Awakn Life Sciences With A Speculative Buy, $8 Target Price Target
April 04, 2022
Tickers
AWKNF
From Benzinga
From Benzinga
Awakn Life Sciences Seeks To Treat Addictions: Gambling, Binge Eating And Compulsive Sexual Behavior
March 28, 2022
Tickers
AWKNF
From Benzinga
This Ketamine-Assisted Therapy Company Is Developing New Ways To Treat Alcohol Addiction
March 24, 2022
From Benzinga
Mindset Pharma, Cybin Among Top Psychedelic Movers Of Today
February 08, 2022
From Benzinga
Mind Medicine, Allied Among Top Psychedelic Movers Of Today
February 02, 2022
From Benzinga
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
January 27, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2022
January 24, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From January 21, 2022
January 21, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From January 20, 2022
January 20, 2022
From Benzinga
From Benzinga
Psychedelic Stock Gainers And Losers From January 18, 2022
January 18, 2022
From Benzinga
Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS
January 18, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From January 17, 2022
January 17, 2022
From Benzinga
Ketamine Therapy Shows Potential In Treatment Of Alcohol Use Disorder, New Study Finds
January 11, 2022
Tickers
AWKNF
From Benzinga
Psyched: MindMed's MDMA Program For Autism, Small Pharma's New Patent, NovaMentis' Orphan Drug Designation
November 01, 2021
From Benzinga
Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent
October 26, 2021
From Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
From Benzinga
From Benzinga
Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study
September 27, 2021
From Benzinga
Is Ketamine A Psychedelic? Depends On Who You Ask
September 22, 2021
From Benzinga
Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial
September 20, 2021
From Benzinga
From Benzinga
Can Ketamine Be Used To Treat Gambling Addiction? Awakn Life Sciences Wants To Find Out
August 24, 2021
Tickers
AWKNF
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.